155 related articles for article (PubMed ID: 31215439)
1. Development and validation of a new tumor-based gene signature predicting prognosis of HBV/HCV-included resected hepatocellular carcinoma patients.
Zhu GQ; Yang Y; Chen EB; Wang B; Xiao K; Shi SM; Zhou ZJ; Zhou SL; Wang Z; Shi YH; Fan J; Zhou J; Liu TS; Dai Z
J Transl Med; 2019 Jun; 17(1):203. PubMed ID: 31215439
[TBL] [Abstract][Full Text] [Related]
2. Prognostic Signature Constructed of Seven Ferroptosis-Related lncRNAs Predicts the Prognosis of HBV-Related HCC.
Wang W; Wang L; Song C; Mu T; Hu J; Feng H
J Gastrointest Cancer; 2024 Mar; 55(1):444-456. PubMed ID: 38006465
[TBL] [Abstract][Full Text] [Related]
3. Establishment of a prognostic signature based on fatty acid metabolism genes in HCC associated with hepatitis B.
Yan P; Luo Y; Huang Z; Mou T; Yang H; Peng D; Wu Z
BMC Gastroenterol; 2023 Nov; 23(1):390. PubMed ID: 37957550
[TBL] [Abstract][Full Text] [Related]
4. The clinical significance of long non-coding RNAs MALAT1 and CASC2 in the diagnosis of HCV-related hepatocellular carcinoma.
Golam RM; Khalil MAF; Shaker OG; Ahmed TI; Elguaad MKA; Hassan EA; El-Ansary MRM; Ismail A; Kandil YI; Mohammed OA; Doghish AS
PLoS One; 2024; 19(5):e0303314. PubMed ID: 38739668
[TBL] [Abstract][Full Text] [Related]
5. Molecular profiles of HCV cirrhotic tissues derived in a panel of markers with clinical utility for hepatocellular carcinoma surveillance.
Gehrau RC; Archer KJ; Mas VR; Maluf DG
PLoS One; 2012; 7(7):e40275. PubMed ID: 22792259
[TBL] [Abstract][Full Text] [Related]
6. A novel ferroptosis phenotype-related clinical-molecular prognostic signature for hepatocellular carcinoma.
Deng T; Hu B; Jin C; Tong Y; Zhao J; Shi Z; Zhang T; Deng L; Sun Z; Chen G; Wang Y
J Cell Mol Med; 2021 Jul; 25(14):6618-6633. PubMed ID: 34085405
[TBL] [Abstract][Full Text] [Related]
7. Molecular signatures associated with HCV-induced hepatocellular carcinoma and liver metastasis.
De Giorgi V; Buonaguro L; Worschech A; Tornesello ML; Izzo F; Marincola FM; Wang E; Buonaguro FM
PLoS One; 2013; 8(2):e56153. PubMed ID: 23441164
[TBL] [Abstract][Full Text] [Related]
8. The mRNA Distribution of Cancer Stem Cell Marker CD90/Thy-1 Is Comparable in Hepatocellular Carcinoma of Eastern and Western Populations.
Luong AB; Do HQ; Tarchi P; Bonazza D; Bottin C; Cabral LKD; Tran LDC; Doan TPT; Crocè LS; Pham HLT; Tiribelli C; Sukowati CHC
Cells; 2020 Dec; 9(12):. PubMed ID: 33322687
[TBL] [Abstract][Full Text] [Related]
9. Identification and validation of a five-gene prognostic signature for hepatocellular carcinoma.
Yang H; Huo J; Li X
World J Surg Oncol; 2021 Mar; 19(1):90. PubMed ID: 33771191
[TBL] [Abstract][Full Text] [Related]
10. The genomic landscape of Mongolian hepatocellular carcinoma.
Candia J; Bayarsaikhan E; Tandon M; Budhu A; Forgues M; Tovuu LO; Tudev U; Lack J; Chao A; Chinburen J; Wang XW
Nat Commun; 2020 Sep; 11(1):4383. PubMed ID: 32873799
[TBL] [Abstract][Full Text] [Related]
11. Establishment of nucleic acid sensing pathways-based model in predicting response to immunotherapy and targeted drug in hepatitis virus-related hepatocellular carcinoma.
Peng X; Shi Y; Zhang B; Xu C; Lang J
J Med Virol; 2023 Sep; 95(9):e29084. PubMed ID: 37721443
[TBL] [Abstract][Full Text] [Related]
12. Development of a Bile Acid-Related Gene Signature for Predicting Survival in Patients with Hepatocellular Carcinoma.
Wang G; Guan J; Yang Q; Wu F; Shao J; Zhou Q; Guo Z; Ren Y; Zhu H; Chen Z
Comput Math Methods Med; 2022; 2022():9076175. PubMed ID: 35592684
[TBL] [Abstract][Full Text] [Related]
13. Altered Protein and Gene Expression of Beclin-1 Correlates with Poor Prognosis of Hcv-Associated Hepatocellular Carcinoma in Egyptian Patients.
Ehsan NA; Mosbeh AM; Elkhadry SW; Gomaa AI; Elsabaawy MM; Elazab DS
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1115-1122. PubMed ID: 33906303
[TBL] [Abstract][Full Text] [Related]
14. Multi-cohort validation study of a four-gene signature for risk stratification and treatment response prediction in hepatocellular carcinoma.
Liu C; Xiao Z; Wu S; Yang Z; Ji G; Duan J; Zhou T; Cao J; Liu X; Xu F
Comput Biol Med; 2023 Dec; 167():107694. PubMed ID: 37956625
[TBL] [Abstract][Full Text] [Related]
15. Harnessing the RNA interference pathway to advance treatment and prevention of hepatocellular carcinoma.
Arbuthnot P; Thompson LJ
World J Gastroenterol; 2008 Mar; 14(11):1670-81. PubMed ID: 18350598
[TBL] [Abstract][Full Text] [Related]
16. Distinct molecular etiologies of male and female hepatocellular carcinoma.
Natri HM; Wilson MA; Buetow KH
BMC Cancer; 2019 Oct; 19(1):951. PubMed ID: 31615477
[TBL] [Abstract][Full Text] [Related]
17. Imaging-based surrogate markers of transcriptome subclasses and signatures in hepatocellular carcinoma: preliminary results.
Taouli B; Hoshida Y; Kakite S; Chen X; Tan PS; Sun X; Kihira S; Kojima K; Toffanin S; Fiel MI; Hirschfield H; Wagner M; Llovet JM
Eur Radiol; 2017 Nov; 27(11):4472-4481. PubMed ID: 28439654
[TBL] [Abstract][Full Text] [Related]
18. Identification of a novel gene pairs signature in the prognosis of gastric cancer.
Peng PL; Zhou XY; Yi GD; Chen PF; Wang F; Dong WG
Cancer Med; 2018 Feb; 7(2):344-350. PubMed ID: 29282891
[TBL] [Abstract][Full Text] [Related]
19. A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery.
Crouchet E; Bandiera S; Fujiwara N; Li S; El Saghire H; Fernández-Vaquero M; Riedl T; Sun X; Hirschfield H; Jühling F; Zhu S; Roehlen N; Ponsolles C; Heydmann L; Saviano A; Qian T; Venkatesh A; Lupberger J; Verrier ER; Sojoodi M; Oudot MA; Duong FHT; Masia R; Wei L; Thumann C; Durand SC; González-Motos V; Heide D; Hetzer J; Nakagawa S; Ono A; Song WM; Higashi T; Sanchez R; Kim RS; Bian CB; Kiani K; Croonenborghs T; Subramanian A; Chung RT; Straub BK; Schuppan D; Ankavay M; Cocquerel L; Schaeffer E; Goossens N; Koh AP; Mahajan M; Nair VD; Gunasekaran G; Schwartz ME; Bardeesy N; Shalek AK; Rozenblatt-Rosen O; Regev A; Felli E; Pessaux P; Tanabe KK; Heikenwälder M; Schuster C; Pochet N; Zeisel MB; Fuchs BC; Hoshida Y; Baumert TF
Nat Commun; 2021 Sep; 12(1):5525. PubMed ID: 34535664
[TBL] [Abstract][Full Text] [Related]
20. SIMarker: Cellular similarity detection and its application to diagnosis and prognosis of liver cancer.
Tong M; Luo S; Gu L; Wang X; Zhang Z; Liang C; Huang H; Lin Y; Huang J
Comput Biol Med; 2024 Mar; 171():108113. PubMed ID: 38368754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
